A McMaster researcher is one of four scientists raising the issue that Ebola may be silently immunizing large numbers of people, who never fall ill or infect others yet become protected from future infection. Their letter was published today in the medical journal The Lancet.
If true, this finding could have significant ramifications for both projections of how widespread the disease will be, and strategies policy makers and health workers should use to contain the disease, say the authors.
"Although resources on the ground are scarce, now is the best time to learn more about immunity to Ebola, and the sooner we know the sooner the knowledge can be used to stop the epidemic," said Jonathan Dushoff, an associate professor of biology and an investigator with the Michael G. DeGroote Institute for Infectious Disease Research.
McMaster University researchers have discovered a simple way to predict an adult's future risk of developing Type 2 diabetes.
The study, published in the journal Diabetologia, found that the blood glycaemia level at one hour after drinking a glucose solution of 75 grams beats every known Type 2 diabetes prediction model published to date.
"Having the one-hour plasma glucose (1h-PG) information alone is sufficient to identify people who are more at risk for developing Type 2 diabetes in the future," said David Meyre, the paper's senior author and an associate professor in the Department of Clinical Epidemiology and Biostatistics at McMaster's Michael G. DeGroote School of Medicine. "Only 30% of non-diabetic middle-aged adults in the study displayed a high 1h-PG (higher than 8.9 mmol/l), but they accounted for 75% of all future diabetic cases".